Back
Caesars Entertainment Vs. Kymera Therapeutics Industry Stock Comparison
Buy
64
CZR
Caesars Entertainment
Last Price:
45.51
Seasonality Move:
4.71%
Buy
71
KYMR
Kymera Therapeutics
Last Price:
46.41
Seasonality Move:
65.72%
Buy
64
Caesars Entertainment (CZR)
is a Buy
Is Caesars Entertainment a Buy, Sell or Hold?
- The current Caesars Entertainment [CZR] share price is $44.64. The Score for CZR is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- CZR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CZR Stock Price Chart
What is Caesars Entertainment's stock price today?
-
The Caesars Entertainment share price today is $44.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CZR is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CZR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.65 | Buy |
Relative Strength Index (14 RSI): | 63.4 | Buy |
Chaikin Money Flow: | -1854531 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.94 - 44.32) | Buy |
Bollinger Bands (100): | (35.06 - 41.04) | Buy |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 59.12 | Buy |
Chaikin Money Flow: | 317205 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.81 - 49.49) | Buy |
Bollinger Bands (100): | (34.86 - 47.92) | Buy |
CZR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.43 | Buy |
20-day SMA: | 42.89 | Buy |
50-day SMA: | 39.33 | Buy |
200-day SMA: | 39.66 | Buy |
8-day EMA: | 44.35 | Buy |
20-day EMA: | 42.86 | Buy |
50-day EMA: | 40.51 | Buy |
200-day EMA: | 40.29 | Buy |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.58 | Buy |
20-day SMA: | 46.67 | Buy |
50-day SMA: | 46.11 | Buy |
200-day SMA: | 38.62 | Buy |
8-day EMA: | 45.67 | Buy |
20-day EMA: | 45.85 | Buy |
50-day EMA: | 45.2 | Buy |
200-day EMA: | 38.5 | Buy |
Caesars Entertainment Earnings Growth & CZR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.75 per share, and an increase next year of $2.27 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Caesars Entertainment Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |